A recent study analyzing the spatiotemporal genomic architecture of glioblastoma found that mutations of a PI3K gene were commonly clonal, early events of tumorigenesis, and affected the tumor response to therapies (44). This evidence concerns the gene PIK3CG and neoplasm.